GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Antares Pharma, Inc. (ATRS) [hlAlert]

Rating:
Buy AIS
up 47.15 %

Antares Pharma, Inc. (AIS) rated Buy with price target $3 by Roth Capital

Posted on: Friday,  Jan 8, 2010  11:25 AM ET by Roth Capital

Roth Capital rated Buy Antares Pharma, Inc. (NASDAQ: ATRS) on 01/08/2010, when the stock price was $1.23. Since
then, Antares Pharma, Inc. has gained 47.15% as of 01/25/2016's recent price of $1.81.
If you would have followed this Roth Capital's recommendation on ATRS, you would have gained 47.15% of your investment in 2208 days.

Antares Pharma, Inc. (Antares) is a product development and pipeline company with drug delivery platforms, including Advanced Transdermal Delivery (ATD) gels, disposable pressure assisted auto injection systems (Vibex), reusable needle-free injection systems (VISION), disposable pen injection systems and oral disintegrating (Easy Tec) tablets. Two of these platforms have generated United States Food and Drug Administration (FDA) approved products. The Company develops, produces and markets pharmaceutical delivery products, including transdermal gels, oral disintegrating tablets and reusable needle-free and disposable pressure assisted auto injector and pen injector systems. The Company has operating facilities in the United States and Switzerland. Its United States operation manufactures and markets reusable needle-free injection devices and related disposables, and develops disposable pressure assisted auto injector and pen injector systems.

ROTH researches emerging growth equities in the media, technology, telecommunications, healthcare, consumer, energy and industrial sectors. The research is focused on companies with market capitalization of between $100 million - $1 billion. Our coverage universe includes approximately 180 small cap growth companies around the globe including several companies from China. With an average market cap of approximately $500 million, our objective is to identify rapidly growing companies with significant long term growth prospects.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
1/8/2010 11:25 AM Buy
None
1.23 3.00
as of 1/1/0001
1 Week   
1 Month   
3 Months   
1 YTD   

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy